ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ACAD on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
170M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
168M
Holdings value
$3.58B
% of all portfolios
0.004%
Grand Portfolio weight change
0%
Number of holders
326
Number of buys
180
Number of sells
-137
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11.9% $293M 19.9M BlackRock, Inc. 31 Jan 2025
RTW INVESTMENTS, LP 4.2% -20% $152M -$33.3M 7.14M -17.9% RTW Investments, LP 30 Sep 2025

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 168M $3.58B -$46.3M $21.34 326
2025 Q2 170M $3.66B -$28.4M $21.57 308
2025 Q1 171M $2.85B +$139M $16.61 315
2024 Q4 163M $2.99B +$135M $18.35 292
2024 Q3 156M $2.4B -$102M $15.38 257
2024 Q2 161M $2.62B -$8.48M $16.25 265
2024 Q1 161M $2.98B -$11.7M $18.49 266
2023 Q4 160M $4.99B +$146M $31.31 272
2023 Q3 156M $3.25B -$82.5M $20.84 246
2023 Q2 159M $3.81B +$45.6M $23.95 232
2023 Q1 158M $2.97B +$53.4M $18.82 231
2022 Q4 156M $2.48B +$28.7M $15.92 221
2022 Q3 153M $2.5B +$30.4M $16.36 213
2022 Q2 151M $2.12B +$730K $14.09 229
2022 Q1 147M $3.56B -$19.9M $24.22 254
2021 Q4 148M $3.46B +$79.7M $23.34 238
2021 Q3 145M $2.41B -$85.7M $16.61 221
2021 Q2 148M $3.61B +$54.4M $24.39 238
2021 Q1 145M $3.74B -$222M $25.80 258
2020 Q4 148M $7.9B -$104M $53.46 298
2020 Q3 150M $6.19B -$100M $41.25 262
2020 Q2 153M $7.4B -$42.5M $48.47 292
2020 Q1 154M $6.5B +$190M $42.25 243
2019 Q4 149M $6.39B +$119M $42.78 271
2019 Q3 146M $5.27B +$306M $35.99 230
2019 Q2 138M $3.69B +$147M $26.73 195
2019 Q1 138M $3.7B -$452K $26.85 197
2018 Q4 139M $2.25B +$303M $16.17 174
2018 Q3 120M $2.49B +$111M $20.76 179
2018 Q2 117M $1.78B -$138M $15.27 179
2018 Q1 122M $2.74B +$37.3M $22.47 190
2017 Q4 120M $3.61B +$37.1M $30.11 208
2017 Q3 118M $4.44B -$56.1M $37.67 207
2017 Q2 120M $3.34B +$82.8M $27.89 199
2017 Q1 120M $4.11B +$170M $34.38 215
2016 Q4 121M $3.49B +$85M $28.84 217
2016 Q3 118M $3.75B +$217M $31.81 226
2016 Q2 111M $3.61B +$14.5M $32.46 223
2016 Q1 110M $3.09B +$352M $27.96 210
2015 Q4 97.5M $3.47B -$46M $35.65 209
2015 Q3 98.6M $3.26B +$13.5M $33.07 184
2015 Q2 98.2M $4.12B +$66M $41.88 187
2015 Q1 97.3M $3.17B +$38.3M $32.59 193
2014 Q4 96.3M $3.06B +$57.8M $31.75 182
2014 Q3 94.2M $2.33B -$12.4M $24.76 162
2014 Q2 95.1M $2.15B +$59.7M $22.59 160
2014 Q1 90.9M $2.21B +$189M $24.33 164